Misuse of Drugs (Amendment No. 3) Regulations 2019

Status:

Published in Subsidiary Legislation Supplement
on 30 Apr 2019

Search within Legislation

Search Results

No. S 353

Misuse of Drugs Act

(CHAPTER 185)

Misuse of Drugs
(Amendment No. 3)
Regulations 2019

In exercise of the powers conferred by section 58(1) of the Misuse of Drugs Act, the Minister for Home Affairs makes the following Regulations:

Citation and commencement

1. These Regulations are the Misuse of Drugs (Amendment No. 3) Regulations 2019 and come into operation on 1 May 2019.

Amendment of Second Schedule

2. The Second Schedule to the Misuse of Drugs Regulations (Rg 1) is amended —

(a)

by inserting, immediately below the item “Dextromoramide” in paragraph 1, the following item:

“(2S)-2,6-Diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide (also known as Lisdexamphetamine or Lisdexamfetamine) and its stereoisomers”;

(b)

by inserting, immediately after item (9) of paragraph 10, the following items:

“(9AA)	Cyclopropylfentanyl
(9AB)	4-Fluorobutyrfentanyl (also known as para-Fluoro-butyrfentanyl or p-Fluoro-butyrfentanyl)
(9AC)	2-Fluorofentanyl (also known as ortho‑Fluorofentanyl)
(9AD)	3-Fluorofentanyl (also known as meta‑Fluorofentanyl)
(9AE)	4-Fluorofentanyl (also known as para‑Fluorofentanyl)”;

(c)

by inserting, immediately after item (10) of paragraph 10, the following items:

“(10A)	Methoxyacetylfentanyl
(10B)	4-Methoxybutyrfentanyl (also known as para-Methoxy-butyrfentanyl or p-Methoxy-butyrylfentanyl)”; and

(d)

by deleting item (12) of paragraph 10.

Amendment of Fourth Schedule

3. The Fourth Schedule to the Misuse of Drugs Regulations is amended —

(a)

by inserting, immediately after item (30) of paragraph 1, the following item:

“(31)

4-Phenyl-N-(2-phenylethyl)piperidin-4-yl acetate (also known as 1-Phenethyl-4-phenyl-4-piperidinol acetate or PEPAP)”;

(b)

by deleting the word “N‑Ethylpentylone” in item (1AC) of paragraph 15 and substituting the words “1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) or N‑Ethylpentylone or N‑Ethylnorpentylone or Ephylone”;

(c)

by deleting item (1) of paragraph 17 and substituting the following items:

“(1)	N-(Adamant-1-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as Adamantyl CHMINACA or SGT-37)
(1AAA)	N-(1-Adamantyl)-5-fluoropentyl-1H-indazole-3-carboxamide (also known as 5-Fluoro-APINACA or 5F‑AKB48) and its fluoro positional isomers in the pentyl group”;

(d)

by inserting, immediately after the words “also known as” in item (2BA) of paragraph 17, the words “N‑(1‑Amino‑3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide or”;

(e)

by inserting, immediately after item (10) of paragraph 17, the following item:

“(10AA)

3,4-Dichloromethylphenidate and its dichloro positional isomers in the phenyl ring (also known as 3,4‑DCMP)”;

(f)

by inserting, immediately after item (20A) of paragraph 17, the following item:

“(20AA)

1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide (also known as 5-Fluoro-cumyl-PICA) and its phenylpropyl isomers and their respective fluoro positional isomers in the pentyl group”;

(g)

by deleting the word “MMB-FUBINACA” in item (28E) of paragraph 17 and substituting the words “Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate or MMB‑FUBINACA or AMB‑FUBINACA or FUB‑AMB”;

(h)

by inserting, immediately after the words “also known as” in item (31A) of paragraph 17, the words “1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide or”;

(i)

by inserting, immediately after item (35) of paragraph 17, the following item:

“(35A)

Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate (also known as 5-Fluoro-SDB-005) and its fluoro positional isomers in the pentyl group”;

(j)

by inserting, immediately after item (36A) of paragraph 17, the following item:

“(36AA)

Naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate (also known as SDB‑005)”; and

(k)

by deleting item (38AA) of paragraph 17.

[G.N. Nos. S 390/99; S 231/2000; S 436/2000; S 140/2001; S 492/2001; S 506/2005; S 490/2006; S 108/2007; S 525/2010; S 684/2010; S 270/2013; S 322/2014; S 571/2014; S 253/2015; S 199/2016; S 193/2017; S 234/2018; S 588/2018; S 88/2019; S 151/2019]

Made on 25 April 2019.

PANG KIN KEONG

Permanent Secretary,
Ministry of Home Affairs,
Singapore.

[MHA 112/2/0049; AG/LEGIS/SL/185/2015/2 Vol. 2]